Modern Health, a global workplace mental health platform, announced the appointment of Dr. Neha Chaudhary as Chief Medical Officer. A double board-certified child, adolescent, and adult psychiatrist with extensive digital health experience, Dr. Chaudhary will lead the company’s clinical team, which collectively has over 135 years of experience and over 175 peer-reviewed publications, to continue to deliver…
Liquidia Corporation announced the appointment of Rajeev Saggar, M.D., to the position of Chief Medical Officer. In this role, Dr. Saggar will oversee all aspects of research, clinical development, medical affairs, and regulatory affairs for Liquidia, assuming responsibilities on July 18, 2022. Roger Jeffs, Chief Executive Officer of Liquidia, said: “We are excited to add…
Sitryx Therapeutics Ltd, a biopharmaceutical company pioneering the field of immunometabolism, announced the appointment of Dr. Ravi M. Rao as its Chief Medical Officer. Dr. Rao is a rheumatologist and pharmaceutical physician with over fifteen years of leadership experience in both large and mid-sized pharmaceutical and biotechnology companies with a wide range of therapeutic area expertise including…
Australian and US MedTech start-up Nutromics, a global leader in DNA-based biosensors, announced that Dr Agim Beshiri, most recently Senior Medical Director at Abbott Laboratories, has joined the organisation as its inaugural Chief Medical Officer (CMO). Dr Beshiri is an accomplished senior medical device executive with special expertise in developing and implementing diagnostics research for biomarkers…
Simcere, a manufacturer and supplier of generic pharmaceuticals in the Chinese market, has named Bijoyesh Mookerjee, M.D., as its Chief Medical Officer, Oncology. Bijoyesh will be responsible for Simcere’s oncology clinical pipeline strategy and development, enhancing our global research capability, as well as advancing the company’s international development, the statement said. “Welcome Dr. Bijoyesh Mookerjee to join Simcere…
Alligator Bioscience announced the appointment of Sumeet Ambarkhane, MD, as its Chief Medical Officer. In this role, Sumeet will provide medical leadership and direction in the development of Alligator’s best-in-class preclinical and clinical pipeline, including Alligator’s lead assets mitazalimab, a CD40 agonist currently in Phase II clinical development, and ATOR-1017, a 4-1BB agonist in Phase…
Insilico Medicine, an end-to-end AI-powered drug discovery company, has announced the appointment of Robert Spiegel as acting CMO to oversee the clinical translation of its preclinical pipeline assets. Dr. Spiegel brings over 35 years of extensive R&D executive and operational experience in biopharmaceuticals and as an advisor to venture capital and private equity firms. “It…
Ceribell, Inc., innovator of the Rapid Response EEG, a novel non-invasive brain monitor, announced that Diku Mandavia, MD, has joined the company as Chief Medical Officer. With 27 years of clinical experience and 14 years of commercial medical device experience, Dr. Mandavia is recognized for his vision in establishing the point-of-care ultrasound as the new…
Nektar Therapeutics, a biopharmaceutical company, announced that it has appointed Brian Kotzin, MD as Interim Chief Medical Officer, Head of Development effective immediately. Since 2017, Dr. Kotzin has served as Senior Vice President, Clinical Development and Head of Immunology at Nektar. Wei Lin will be leaving the company to pursue another opportunity. “We are pleased…
Intra-Cellular Therapies, a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, announced the promotion of Dr. Suresh Durgam to the position of Chief Medical Officer. Dr. Suresh Durgam succeeds Dr. Andrew Satlin, who will step down as Chief Medical Officer, and will leave the Company effective October…
Braid Health, a digital health innovation company that develops AI-powered diagnostic tools for radiology, announced the appointment of Rajni Natesan as Chief Medical Officer. Prior to this role, Natesan was Co-President and Chief Medical Officer at QT Ultrasound, where she spearheaded new FDA clearances including FDA 510(k) awards and an FDA Breakthrough Device designation, led…
JanOne Inc., a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs and therapies with nonaddictive pain-relieving properties, announced the addition of Amol Soin, MD as the company’s chief medical officer. Soin has been recognized multiple times as one of America’s Top Doctors and is the recipient of the Patient’s Choice Award, an honor given only to the top 1% of physicians in the country.